KRAS and colorectal cancer: A meta-analysis demonstrated that the p.G12V mutation at codon 12 in the KRAS gene increases the risk of recurrence or mortality in patients with colorectal cancer (17,20–21), unlike other KRAS mutations that have only a moderate, non-significant effect on overall survival (22).